|
|
||||||||
Division of Clinical Pharmacology and Toxicology, Clinical Chemistry Department, Ullevaal University Hospital, N-0407 Oslo, Norway
| |
ABSTRACT |
|---|
|
|
|---|
Increase in extracellular Mg2+
concentration ([Mg2+]o) reduces
Ca2+ accumulation during reoxygenation of hypoxic
cardiomyocytes and exerts protective effects. The aims of the present
study were to investigate the effect of increased
[Mg2+]o on Ca2+ influx and
efflux, free cytosolic Ca2+
([Ca2+]i) and Mg2+ concentrations
([Mg2+]i), Ca2+ accumulation in
the presence of inhibitors of mitochondrial or sarcoplasmatic reticulum
Ca2+ transport, and finally mitochondrial membrane
potential (
m). Isolated adult rat cardiomyocytes were
exposed to 1 h of hypoxia and subsequent reoxygenation. Cell
Ca2+ was determined by 45Ca2+
uptake, and the levels of [Mg2+]i and
[Ca2+]i were determined by flow cytometry as
the fluorescence of magnesium green and fluo 3, respectively.
Ca2+ influx rate was significantly reduced by ~40%,
whereas Ca2+ efflux was not affected by increased
[Mg2+]o (5 mM) during reoxygenation.
[Ca2+]i and [Mg2+]i
were increased at the end of hypoxia, fell after reoxygenation, and
were unaffected by increased [Mg2+]o.
Clonazepam, a selective mitochondrial Na+/Ca2+
exchange inhibitor (100 µM), significantly reduced Ca2+
accumulation by 70% and in combination with increased
[Mg2+]o by 90%. Increased
[Mg2+]o, clonazepam, and the combination of
both attenuated the hypoxia-reoxygenation-induced reduction in

m, determined with the cationic dye JC-1 by flow cytometry. A significant inverse correlation was observed between 
m and cell Ca2+ in reoxygenated cells
treated with increased [Mg2+]o and
clonazepam. In conclusion, increased [Mg2+]o
(5 mM) inhibits Ca2+ accumulation by reducing
Ca2+ influx and preserves 
m without
affecting [Ca2+]i and
[Mg2+]i during reoxygenation. Preservation of
mitochondria may be an important effect whereby increased
[Mg2+]o protects the postischemic heart.
magnesium; hypoxia; calcium; flow cytometry; clonazepam
| |
INTRODUCTION |
|---|
|
|
|---|
INCREASED
EXTRACELLULAR MG2+ concentration
([Mg2+]o) has protective effects during
reperfusion of the ischemic human heart (9, 43)
and in different experimental protocols of ischemia-reperfusion (5, 12). However, the underlying mechanisms of action of elevated [Mg2+]o are still obscure.
Ca2+ overload (in addition to oxidative stress) is probably
a major factor causing tissue injury during ischemia/hypoxia
and reperfusion/reoxygenation of the heart (6, 39), and
strategies to reduce Ca2+ overload have been shown to
protect the myocardium in experimental models of reperfusion and
reoxygenation (21, 42). Intracellular organelles like the
sarcoplasmatic reticulum (SR) and mitochondria might accumulate excess
Ca2+ during reperfusion/reoxygenation. Data from Lochner et
al. (23) showed that Ca2+ content was
increased two- to threefold in mitochondria isolated from the
reperfused heart. The role of the SR is more uncertain because
Ca2+-ATPase activity of the SR (the mechanism responsible
for Ca2+ uptake to the SR) is actually reduced during
reoxygenation and reperfusion (44). Both Ca2+
overload and a fall in mitochondrial membrane potential
(
m) may induce mitochondrial permeability transition
(mPT), which is an initiating step for apoptosis and necrosis
(20). Mg2+, being known as nature's own
Ca2+ antagonist, has shown inhibitory action on both
Ca2+ channels (1, 11) and
Na+/Ca2+ exchange (17, 40).
Beneficial effects of high Mg2+ concentrations in
cardioplegic solutions have been associated with reduced free cytosolic
Ca2+ concentration ([Ca2+]i) in a
simulated ischemia model with neonatal rat myocytes
(14) and in an ischemia-reperfusion model with
both mature and aged rabbit hearts (41). Mg2+
has been shown to reduce binding of Ca2+ to the
mitochondrial membrane and to inhibit mPT (19). Recently, in a report (34) from our laboratory, we showed that
elevation of [Mg2+]o to 5 mM reduced cell
Ca2+ accumulation during reoxygenation of hypoxic rat
cardiomyocytes. This effect could be due to decreased influx and/or
increased efflux of Ca2+ by Mg2+. The first
goal of the present study was consequently to test the effect of
increased [Mg2+]o on the influx and efflux
kinetics of Ca2+ during reoxygenation of hypoxic
cardiomyocytes. The second goal was to test whether the inhibitory
effect of increased [Mg2+]o on
Ca2+ accumulation occurs with a reduction in
[Ca2+]i and is linked to an increase in free
cytosolic Mg2+ concentration
([Mg2+]i). The third goal was to investigate
the effect of increased [Mg2+]o on
Ca2+ accumulation in cells treated with an inhibitor of SR
or mitochondrial Ca2+ transport in an attempt to identify
the locus (loci) of action. The latter was also the reason for
investigating the effect of increased [Mg2+]o
on 
m during reoxygenation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Chemicals and materials. The following chemicals were obtained from Sigma (St. Louis, MO): BSA (essentially fatty acid-free), DL-carnitine, dibutyl phthalate, ouabain, trypsin, cyclopiazonic acid, calcimycin, and SDS. Joklik's minimum essential medium (MEM) was obtained from Life Technologies (Paisley, UK). Collagenase and deoxyribonuclease were obtained from Worthington Biochemical (Lakewood, NJ). 45Ca2+ was obtained from DuPont de Nemours, NEN Division (Dreiech, Germany). Micro bicinchoninic acid (BCA) Protein Assay Reagent was obtained from Pierce (Rockford, IL). 3,4-Dichlorobenzamil (DCB), fluo 3-AM, magnesium green (MgG), calcium calibration buffer kit No. 2, and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) were obtained from Molecular Probes (Eugene, OR). Di-isononyl phthalate was obtained from Fluka Chemie (Buchs, Switzerland). Opti-Fluor was obtained from Packard (Groningen, The Netherlands). Solutions for calibration of the MgG signal were made due to a recipe obtained from Molecular Probes. DMSO was obtained from Merck (Darmstadt, Germany). Clonazepam and polyethylene glycol (PEG) 6000 were obtained from Norwegian Medicinal Depot (Oslo, Norway).
Buffers and solutions.
Normal physiological buffer (NPB) was composed of (in mM) 120.0 NaCl,
3.3 KCl, 1.2 KH2PO4, and 24.0 NaHCO3; pH 7.4. NPB-1 contained NPB supplemented with 0.5 mM CaCl2, 0.8 mM MgSO4, and 1% (wt/vol) BSA.
NPB-2 contained NPB supplemented with 1.0 mM CaCl2, 0.8 mM
MgSO4, and 0.1% (wt/vol) BSA. Aliquots of
MgSO4 (1 M, aqueous solution) was added to the
incubation buffer to increase [Mg2+]o at the
times indicated. The stock solution of DCB (5 mM) was made in PEG (20%
wt/vol, aqueous solution) and further diluted to 1:500 in the
incubation buffer at the time of addition (10 µM DCB and 0.04% PEG).
Clonazepam was dissolved in DMSO (100 mM) and diluted
further to 1:1,000 in the incubation buffer at the start of experiments
(100 µM clonazepam and 0.1% DMSO). In the experiments in which
clonazepam was tested, 0.1% DMSO was added to all test conditions to
exclude any effects of DMSO alone. The stock solution of JC-1 was made
(7.7 mM in DMSO) and kept at
20°C. Before
measurements were made, the JC-1 stock solution was diluted to 1:100
with NPB-2 and added to the cell suspension to give the final
concentration of 12 µM JC-1 (0.13% DMSO).
Isolation of cardiomyocytes. Adult male Wistar rats (200-400 g) were obtained from Møllegaard (Skensved, Denmark) and housed in accordance with the conditions set by the Norwegian Council for Animal Research. The investigation conformed with the guidelines of the Norwegian National Institute for Public Health. Cardiomyocytes were isolated by trypsin-collagenase perfusion as previously described (33). Cell suspensions used for experiments contained at least 70% viable cells (trypan blue exclusion), of which at least 95% had an elongated shape. Cell protein was measured according to Smith et al. (36) by Micro BCA Protein Assay Reagent using BSA as the standard.
Incubation.
Cells were incubated in 25-ml Erlenmeyer flasks in NPB-2 supplemented
with trace amounts of 45Ca2+ (
5 × 106
disintegrations · min
1 · ml
1)
in a 37°C water bath. In normoxia (control cells), the cell suspension was gassed with 95% air-5% CO2
(PO2
12-14 kPa) and supplied with 5.5 mM glucose. In hypoxia, cells were added to NPB-2 (no glucose added)
equilibrated with 95% N2-5% CO2
(PO2
1 kPa). At reoxygenation, gas was
changed to 95% air-5% CO2, and buffer was supplied with
5.5 mM glucose. Oxygen tension in the test flasks was checked using an
oxygen electrode (WTW Microprocessor Oximeter Oxi 96, Wissenschaftliche
Technische Werkstätten; Weilheim, Germany) near the bottom of the
Erlenmeyer flask whereto cells were added. Each Erlenmeyer flask was
supplied with an inlet and outlet for gas and continuously gassed for
the indicated time.
Determination of cell Ca2+ and influx kinetics of Ca2+. Cell Ca2+ was determined as rapidly exchangeable Ca2+ by uptake of 45Ca2+ and calculated from the 45Ca2+ content of the cells and the known specific activity of 45Ca2+ in the uptake buffer. Cell membrane Ca2+ transport was stopped by pipetting samples into centrifuge tubes with ice-cold buffer layered over an oil mixture, and cells were separated from buffer by subsequent centrifugation as previously described (34). The data were normalized to the protein content in each cell pellet. The Ca2+ influx rate was determined from the initial, apparently linear uptake of 45Ca2+ after the addition of isotope and exchangeable cell Ca2+ from the apparent equilibrium of 45Ca2+ uptake (plateau level).
Determination of efflux kinetics of Ca2+. Decline of 45Ca2+ content in cells exposed to hypoxia and reoxygenation was used to evaluate Ca2+ efflux. Briefly, cells were loaded with trace amounts of 45Ca2+ during 1 h of hypoxia and 0.5 h of reoxygenation. The cell suspension was then centrifuged (250 g for 30 s), the supernatant was aspirated, and the cells were resuspended in oxygenated buffer (37°C) to dilute extracellular 45Ca2+ and start efflux of the isotope. After 5 min, the centrifugation and resuspension steps were repeated. For each dilution step, the extracellular isotope was diluted by a factor of ~10. To characterize the kinetics of the decline, the radioactivity remaining in the cells was normalized to protein content and subtracted the calculated equilibrium value (the prewash value divided by the product of both dilution factors).
Flow cytometric analysis of [Ca2+]i and [Mg2+]i. Levels of [Ca2+]i and [Mg2+]i were measured by flow cytometry as the fluorescence of fluo 3 and MgG, respectively. Fluo 3-AM and MgG are membrane permeable. After entering the cells, these esters are cleaved by intracellular esterases to yield the relatively cell-impermeant fluorescent indicators fluo 3 and MgG, respectively. Fluo 3-AM and MgG were dissolved in DMSO right before each experiment, added to the incubation buffer (NPB-2) to give the final concentration of 4.5 µM fluo 3 or 5 µM MgG (0.5% DMSO), and were present during the whole experiment. Samples were directly applied to the flow cytometer without any washing step to remove the extracellular indicators. Preliminary testing showed that the level of fluorescence in all groups (normoxic control, hypoxia/reoxygenation ± Mg2+) was slightly reduced, and to the same degree by a washing step, probably due to some loss of probe from the cells. A FACSort (Becton-Dickinson; Rutherford, NJ) flow cytometer equipped with a 488-nm argon ion laser and supplied with the Cell Quest software was used to measure fluorescence signals of fluo 3 and MgG in the cells. Fluo 3 and MgG, unlike ultraviolet light-excited indicators (e.g., fura 2), do not exert any spectral shift. Signals were obtained using a 530-nm bandpass filter (FL-1 channel) for both indicators. Each determination was based on a mean fluorescence intensity of 5,000 cells in arbitrary units. The fluorescence intensity of unloaded cells (background signal) of both indicators was ~2% of signals of indicator-loaded cells.
Calibration of fluo 3 and MgG fluorescence. Cells were loaded with the indicator for 1 h in NPB-2 (normoxic, 37°C and 5.5 mM glucose). The cell suspension was then centrifuged (250 g for 30 s). The cell pellet was dispersed in 25-ml NPB-2 (nominally Ca2+ and Mg2+ free) and centrifuged (250 g for 30 s). The cell pellet was then washed twice with 5 ml of zero-Ca2+ buffer (calcium calibration buffer kit No. 2, Molecular Probes) in the case of fluo 3-loaded cells and Mg2+ calibration buffer component A (see MATERIALS AND METHODS) for MgG-loaded cells. Fluo 3-loaded cardiomyocytes were then exposed to various Ca2+ concentrations (0, 58, 135, 315, and 1,215 nM). [Ca2+]i was equilibrated with extracellular Ca2+ by addition of the ionophore calcimycin (50 µM). MgG-loaded cells were exposed to various Mg2+ concentrations (0, 0.18, 0.36, 0.72, 1.44, 2.88, and 5.76 mM). [Mg2+]i was equilibrated with extracellular Mg2+ by the addition of calcimycin (50 µM). Different Mg2+ concentrations were made by mixing Mg2+ calibration buffer components A and B [component A was composed of (in mM) 115 KCl, 20 NaCl, and 10 Tris (pH 7); and component B was composed of (in mM) 35 MgCl2, 115 KCl, 20 NaCl, and 10 Tris (pH 7.05)]. These were made using the recipe of the Mg2+ calibration standard kit (M-3120), which is no longer produced by Molecular Probes. Each determination was based on a mean fluorescence intensity of 5,000 cells in arbitrary units. The particular indicator (4.5 µM fluo 3 or 5 µM MgG) was present in all solutions used in the signal calibration protocol in likeness with the experiments. Ca2+ binding [dissociation constant (Kd) of 325 nM] results an increase in fluorescence intensity of fluo 3 by ~100-fold. Fluo 3 has an eight times higher affinity for Ca2+ than Mg2+ (data given by Molecular Probes). However, MgG, like other tricarboxylate aminophenol triacetic acid chelators, binds Ca2+ with high affinity. The interference with Mg2+ measurements due to Ca2+ binding becomes significant when Ca2+ concentrations exceed ~1 µM (13, 18). Leyssens et al. (22) found that the Kd of MgG for Ca2+ was 4.7 µM in rat cardiomyocytes, whereas the Kd of MgG for Mg2+ is ~1 mM. Consequently, we did exactly the same calibration experiments mentioned above but incubated instead the MgG-loaded cells with Ca2+ calibration buffers and fluo 3-loaded cells with Mg2+ calibration buffers.

m measurements with JC-1.
The dye JC-1 has recently been evaluated as an optimal dye for
measuring 
m in cardiomyocytes (24). JC-1
is a lipophilic and cationic dye that exhibits potential-dependent
accumulation in negatively charged mitochondria. At low concentrations
(low 
m), JC-1 exists mainly in a monomeric form,
which emits green fluorescence. JC-1 at high concentrations (high

m) forms aggregates called "J" complexes, which
emit red fluorescence at 590 nm. Thus a reduction in the ratio of red
to green fluorescence indicates a fall in 
m. Cells
were loaded with 12 µM JC-1 for 10 min at 37°C and then immediately
applied to the flow cytometer for signal recording using the 530-nm
(FL-1 channel) and 585-nm (FL-2 channel) bandpass filters
simultaneously. Each determination was based on the ratio of red to
green mean fluorescence intensities measured in arbitrary units from
5,000 cells.
Statistics. All experiments were performed as paired comparisons. Statistical analysis was performed using Statgraphics Plus software (version 4.0, Manugistics; Rockville, MD). Statistical analysis of multigroup comparisons was performed by one-way ANOVA, and the method to discriminate among the means was Fisher's least significant difference (LSD) method. Statistical analysis of two-sample comparisons was performed by Student's t-test (two-sided). P < 0.05 was considered to be significant.
| |
RESULTS |
|---|
|
|
|---|
Cell Ca2+ during
normoxia and reoxygenation of hypoxic cardiomyocytes.
Cell Ca2+ was in the range of 2.5-3 nmol/mg protein at
apparent equilibrium in the normoxic cells.
45Ca2+ uptake reached a plateau after 1-2
min irrespective of adding 45Ca2+ to the buffer
at 10 or 120 min and was virtually unchanged during the time course of
the experiments (Fig. 1). In cells
exposed to hypoxia and reoxygenation, cell Ca2+
significantly increased after reoxygenation from 3 to 12 nmol/mg protein (Fig. 1). The equilibrium values for exchangeable cell Ca2+ in reoxygented cells at 180 min were similar
irrespective of adding 45Ca2+ at the start of
incubation or at 120 min (Fig. 1). 45Ca2+
apparently equilibrated more slowly with the pool of exchangeable Ca2+ in reoxygenated cells than in normoxic cells at 120 min (Fig. 1, inset).
|
Effect of increased
[Mg2+]o on cell
Ca2+ during hypoxia and reoxygenation.
To investigate whether the effect of Mg2+ was exerted
during hypoxia or reoxygenation, [Mg2+]o was
increased to 5 mM either from the start of the experiments or at the
onset of reoxygenation. Both treatments reduced reoxygenation-mediated Ca2+ accumulation to the same degree (50%) compared with
hypoxia- and reoxygenation-treated cells in the presence of normal
[Mg2+]o (0.8 mM). Lowering
[Mg2+]o to 0.3 mM during
hypoxia-reoxygenation did not alter cell Ca2+ accumulation
compared with normal [Mg2+]o (0.8 mM) (Fig.
2).
|
Effect of increased
[Mg2+]o on
Ca2+ influx during
reoxygenation.
Trace amounts of 45Ca2+ were added to cells
exposed to 60 min of hypoxia and 30 min of reoxygenation.
[Mg2+]o increased to 5 mM at the onset of
reoxygenation significantly reduced the initial rate of
45Ca2+ uptake (up to 5 min), reflecting a
reduced influx velocity of Ca2+ (Fig.
3A). Because
45Ca2+ uptake was apparently not linear for 5 min (Fig. 3A, inset), a separate set of
experiments was performed (Fig. 3B) with sample collections
at 2 and 3 min as well. These experiments confirmed that the initial
rate of 45Ca2+ uptake was reduced by elevated
[Mg2+]o. The Na+/Ca2+
exchange inhibitor DCB (10 µM, added at the onset of reoxygenation) also significantly reduced the influx velocity of
45Ca2+ (Fig. 3, A, inset,
and B).
|
Effect of increased
[Mg2+]o on
Ca2+ efflux during
reoxygenation.
To study the effect of elevated [Mg2+]o (5 mM, added at reoxygenation) on Ca2+ efflux, cells were
loaded for 90 min with 45Ca2+ (60 min of
hypoxia and 30 min of reoxygenation). The buffer was then diluted
~100-fold by centrifugation and resuspension. The fractions of
cellular 45Ca2+ (of start value) remaining
after 95, 120, and 180 min were 84, 74, and 40% and 96, 73, and 41%
in the cells exposed to hypoxia-reoxygenation in the absence and
presence of increased [Mg2+]o, respectively,
showing similar efflux kinetics (Fig.
4A). Normoxic control cells
loaded with 45Ca2+ for 90 min and subjected to
buffer dilution also showed the same pattern of decline of isotope
content in the presence of increased [Mg2+]o
(5 mM) added at 60 min as in the presence of normal
[Mg2+]o (0.8 mM; Fig. 4B).
|
[Ca2+]i
during hypoxia and reoxygenation and effect of increased
[Mg2+]o.
The relationship between [Ca2+]i and
fluorescence intensity of fluo 3 in calcimycin-permeablized cells is
shown in Fig. 5. The relationship was
time dependent, approaching a stable level after 180 min of
permeabilization. Figure 5A, inset, shows that
fluo 3 fluorescence in calcimycin-permeablized cells was not influenced by varying [Mg2+]o. Compared with normoxia,
fluo 3 fluorescence intensity was increased 4.5-fold at the end of 60 min of hypoxia, corresponding to an increase in
[Ca2+]i from 60 to 300 nM (Fig.
6A). The fluorescence signal
of fluo 3 rapidly fell at reoxygenation and by the end of experiments was ~30% higher than control cells, corresponding to a
[Ca2+]i of 125 nM in reoxygenated cells and
90 nM in normoxic cells, respectively. Increasing
[Mg2+]o to 5 mM at the onset of reoxygenation
did not affect the fluo 3 signal during reoxygenation (Fig.
6B). The hypoxic group, which received DCB at the onset of
reoxygenation, tended to have ~30-40% lower fluo 3 signal than
control hypoxia-reoxygenation; however, the difference was not
statistically significant. Ouabain-treated cells exposed to hypoxia and
reoxygenation showed a similar increase in fluo 3 fluorescence signal
at the end of 60 min of hypoxia as without ouabain, but no significant
fall in fluo 3 fluorescence was achieved during reoxygenation. Elevated
[Mg2+]o during reoxygenation of hypoxic and
ouabain-treated cells had no effect on fluo 3 fluorescence.
|
|
[Mg2+]i
in hypoxia and reoxygenation and effect of increased
[Mg2+]o.
The relationship between [Mg2+]i and
fluorescence intensity of MgG in calcimycin-permeablized cells is shown
in Fig. 7A. The relationship
approached a stable level after 180 min of permeabilization. Figure
7A, inset, shows that MgG fluorescence in
calcimycin-permeablized cells is less sensitive to increasing
Ca2+ than to increasing Mg2+ concentrations.
MgG fluorescence intensity was increased twofold compared with normoxic
control cells at the end of hypoxia (60 min), showing an increased
[Mg2+]i at the end of the hypoxic period
(Fig. 7B). The fluorescence signal of MgG started to fall at
the onset of reoxygenation and by the end of the experiments was
~20% higher than in normoxic control cells. In cells exposed to
hypoxia-reoxygenation in the presence of 5 mM
[Mg2+]o, mean MgG fluorescence intensity
tended to be higher, but no significant difference was found.
|
Effect of increased
[Mg2+]o in
combination with clonazepam or cyclopiazonic acid on
Ca2+ accumulation.
The effect of clonazepam and cyclopiazonic acid on cell
Ca2+ was tested to investigate the possible role of the
mitochondria and SR during reoxygenation. Clonazepam (100 µM, added at start) reduced the elevation in cell
Ca2+ by 85% at 2 h and 70% at 3 h. Increased
[Mg2+]o significantly increased the
inhibitory effect on Ca2+ accumulation when combined with
clonazepam (Fig. 8A). The
effect of cyclopiazonic acid (SR Ca2+-ATPase inhibitor) on
hypoxia-reoxygenation-mediated Ca2+ accumulation was also
studied. Surprisingly, cyclopiazonic acid (20 µM, added
at start) significantly amplified the reoxygenation-induced increase in
cell Ca2+ by 45% at 180 min compared with
hypoxia-reoxygenation without cyclopiazonic acid. This cyclopiazonic
acid-induced increase in cell Ca2+ was abolished by
increased [Mg2+]o (5 mM, added at
reoxygenation). Actually, the cells treated with the cyclopiazonic acid
and Mg2+ had significantly lower values than cells
exposed to hypoxia-reoxygenation without treatment (Fig.
8B).
|
Effect of increased
[Mg2+]o,
clonazepam, and their combination on 
m during
reoxygenation.
The ratio of red to green fluorescence of JC-1 showed linear dose
dependence up to 20 µM JC-1 after 10 min of normoxic incubation (R2 = 0.953, linear regression). Cyanide (5 mM) reduced markedly the red-to-green fluorescence ratio of JC-1 after
10 and 60 min of normoxic incubation with JC-1, as shown in Fig.
9. The effect of clonazepam (100 µM, added at start) and increased
[Mg2+]o (supplemented at reoxygenation) on

m was investigated in cells exposed to 1 h of
hypoxia and 1 h of reoxygenation using the JC-1 fluorescence
ratio. Reoxygenated cells had a 24% lower red-to-green fluorescence
ratio than normoxic cells, indicating a fall in 
m.
Cells exposed to hypoxia and reoxygenation in the presence of 5 mM
[Mg2+]o showed a significantly higher
(17 ± 3%) red-to-green fluorescence ratio of JC-1 than control
hypoxia-reoxygenation-treated cells. Reoxygenated cells in the presence
of 100 µM clonazepam (added at start of experiments) showed 40%
higher and the combination of clonazepam and elevated
[Mg2+]o showed a 50% higher red-to-green
fluorescence ratio of JC-1, respectively, compared with control
reoxygenated cells (Fig.
10A). The
red-to-green fluorescence ratio of JC-1 was inverse correlated (R2 = 0.975, P < 0.01) to cell
Ca2+ in hypoxia-reoxygenation alone or after treatment with
Mg2+, clonazepam, or the combination of both agents as
shown in Fig. 10B.
|
|
Cell size and granularity.
Forward scatter (FSC) and side scatter (SSC) were determined by flow
cytometry to characterize the effect of
[Mg2+]o and clonazepam on cell size and
granularity. Elevated [Mg2+]o did not alter
FSC (Fig. 11A) or SSC
signals (Fig. 11B); however, clonazepam and the combination
of clonazepam and elevated [Mg2+]o showed
significant attenuation of the reduction of FSC and the increase in SSC
induced by hypoxia and reoxygenation, the combination being most
effective. Clonazepam also reduced lactate dehydrogenase (LDH) release
by 70% (7 determinations from two different cell isolations,
P < 0.05) measured 1 h after
reoxygenation.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study was designed to elucidate the mechanism(s) behind the
effect of increased [Mg2+]o on
Ca2+ accumulation during reoxygenation of hypoxic
cardiomyocytes. By increasing [Mg2+]o to 5 mM
at reoxygenation, Ca2+ accumulation was reduced by
40-50%. Ca2+ influx was significantly reduced,
whereas Ca2+ efflux kinetics were unaltered, and
[Ca2+]i and [Mg2+]i
were not detectably affected. Increased
[Mg2+]o also reduced the
reoxygenation-induced fall in 
m assessed by JC-1
fluorescence and potentiated the effect of clonazepam on
Ca2+ accumulation, 
m, FSC, and SSC.
Cell Ca2+ in hypoxia and reoxygenation. The marked increase in cell Ca2+ after hypoxia and reoxygenation observed in this study is in agreement with previous reports (8, 25, 33). The present results showing rapidly attained equilibrium of 45Ca2+ in normoxic cells within 2-5 min of addition to the extracellular buffer also are in agreement with the literature (3, 32). The similarity in equilibration pattern of normoxic cells with 45Ca2+ added either 10 min after start of incubation or 2 h after start of incubation indicates that Ca2+ influx and efflux mechanisms remained intact at normoxia during the experiment. Also, uptake of 45Ca2+ added to cells after exposure to 1 h of hypoxia and 1 h of reoxygenation approached the same value of equilibrium (exchangeable) cell Ca2+ (at 3 h) as in cells exposed to the same protocol of hypoxia and reoxygenation and with 45Ca2+ added at the start of the experiment. This finding indicates that 45Ca2+ equilibrates with the same exchangeable pool of Ca2+ also when added after increasing the size of the pool by hypoxia and reoxygenation and that the availability of the Ca2+ pool for exchange with 45Ca2+ was maintained. The longer time needed to equilibrate exchangeable Ca2+ with 45Ca2+ in hypoxia- and reoxygenation-treated cells than in normoxia could be due partly to the increase in size of the pool, partly to slower sarcolemmal influx and efflux rates of Ca2+, and possibly also to slower exchange of Ca2+ between the cytosol and intracellular stores.
Effect of increased [Mg2+]o on cell Ca2+ accumulation, Ca2+ influx, and Ca2+ efflux. The observed 40-50% reduction in reoxygenation-induced Ca2+ accumulation by increased [Mg2+]o is in agreement with our previous data (34). The effect of increased [Mg2+]o on Ca2+ accumulation during reoxygenation was similar irrespective of whether [Mg2+]o was increased from the start of hypoxia or increased at the onset of reoxygenation, showing that the effect of Mg2+ was exerted at reoxygenation and not during hypoxia. Our results showing significant reduction of influx velocity of Ca2+ and no effect on the pattern of decline of 45Ca2+ in cells exposed to hypoxia and subsequent reoxygenation indicate that the reduction of Ca2+ accumulation by increased [Mg2+]o during reoxygenation was due to reduced influx of Ca2+. Reduction in Ca2+ accumulation during reoxygenation might conceivably be caused by inhibition of sarcolemmal Ca2+ influx mechanisms such as reverse Na+/Ca2+ exchange, extensively discussed in our recent report (34), and/or inhibition of Ca2+ accumulation in intracellular pool(s), most probably the SR and mitochondria.
Methodological aspects in measurements of [Ca2+]i and [Mg2+]i. A central aspect in the present work is the selectivity of intracellular fluorescence probes for detecting the free ion concentration of Ca2+ and Mg2+ and the actual contamination of signal by other ions than those intended to detect. Fluo 3 is essentially nonfluorescent unless bound to Ca2+, with the maximum fluorescence signal at 1,400 nM Ca2+. Fluo 3 has a Kd of 390 nM for Ca2+ according to the manufacturer (Molecular Probes) in 100 mM KCl, 10 mM MOPS (pH 7.2), and 0-10 mM Ca2+-EGTA at 22°C. This value agrees well with the value found based on our calibration curve in permeabelized cells, which was 305 nM. Fluo 3 exhibits an at least 100-fold Ca2+-dependent fluorescence enhancement (10). Fluo 3 can also bind Mg2+. The relative magnitude of the Ca2+-dependent fluorescence increase of fluo 3 is about eightfold greater than the Mg2+-dependent fluorescence increase in 100 µM Ca2+ and 10 mM Mg2+, respectively (guideline data provided by Molecular Probes). We therefore conclude that Mg2+ was not likely to significantly influence fluo 3 fluorescence in the present experiments. Similarly, MgG can bind both Mg2+ and Ca2+. However, typical physiological Ca2+ concentrations (10 nM-1 µM) do not usually interfere with MgG fluorescence because the affinity of MgG for Ca2+ is low. Leyssens et al. (22) showed that [Mg2+]i can be assessed using MgG and found that the MgG signal was not affected by changes in [Ca2+]i in the range of 100-400 nM evoked by 10 mM caffeine. Additionally, the increase in the MgG signal by the mitochondrial uncoupler carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) was neither significantly affected by removing external Ca2+ nor buffering intracellular Ca2+ with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. Because our measurements of [Ca2+]i showed values of 60 and 300 nM for normoxic and hypoxic cells, respectively, we conclude that our measurement of MgG fluorescence was likely not contaminated by Ca2+ (Kd of MgG for Ca2+ is 6 µM, data reported by Molecular Probes).
Effect of increased [Mg2+]o on [Ca2+]i during hypoxia and reoxygenation. The increase in fluo 3 fluorescence at the end of hypoxia, demonstrating an increase in [Ca2+]i, is in agreement with known changes in [Ca2+]i in cardiac tissue during hypoxia (16) and ischemia (37), probably due to ATP depletion and subsequent inability to maintain Ca2+ gradients across sarcolemma and intracellular stores like the SR. The observed level of fluo 3 fluorescence corresponding to 60 nM in normoxic control cells after 1 h of incubation is in accordance with the value from normoxic cells in data presented by Nishida et al. (27) for end-diastolic [Ca2+]i of 72 ± 6 nM in isolated adult rat cardiomyocytes electrically stimulated at 2 Hz. Increased [Ca2+]i at the end of hypoxia and the subsequent fall in [Ca2+]i starting at reoxygenation is in agreement with reported effects of reoxygenation on [Ca2+]i recovery during reoxygenation (21, 30). The fluo 3 fluorescence stabilized at a level 60% above the normoxic control, indicating permanent disturbance of cellular Ca2+ homeostasis in reoxygenated cells in the present model, compatible with irreversible cell damage also demonstrated by the rounded shape of the cells and the higher proportion of trypan blue-positive cells. Because increased [Mg2+]o did not alter [Ca2+]i, the reduction of Ca2+ accumulation by increased [Mg2+]o indicates reduced intracellular Ca2+ storage by the SR and/or mitochondria.
Effect of increased [Mg2+]o on [Mg2+]i during hypoxia and reoxygenation. To our knowledge, this is the first report on whether increased [Mg2+]o alters [Mg2+]i during reoxygenation of isolated hypoxic cardiomyocytes. Our results showing a large increase in [Mg2+]i at the end of hypoxia were probably a consequence of ATP depletion and reduction of the Mg2+-ATP complex, as shown previously by others (22). Because cells treated with increased [Mg2+]o did not show higher MgG fluorescence during reoxygenation than cells in the presence of normal [Mg2+]o (0.8 mM) (and not lower [Ca2+]i as discussed in Effect of increased [Mg2+]o on [Ca2+]i during hypoxia and reoxygenation), it appears that the primary effect of increased [Mg2+]o was not exerted by elevating [Mg2+]i or lowering [Ca2+]i. We speculate that the effect of increased [Mg2+]o could be exerted on extracellular sites such as the sarcolemmal transporters of Ca2+ and/or intracellular organelles like the mitochondria and SR, possibly influenced by the extracellular concentration of divalent cations like Mg2+ and Ca2+ via signal transduction pathway(s).
Effect of Mg2+ in combination with clonazepam on Ca2+ accumulation during reoxygenation. The large inhibitory effect of the selective mitochondrial Na+/Ca2+ exchange inhibitor clonazepam on reoxygenation-induced Ca2+ uptake indicates that mitochondrial reverse Na+/Ca2+ exchange might be responsible for a significant part of the cellular Ca2+ accumulation in the present model. Reperfusion of the myocardium has been shown to be associated with marked increase in mitochondrial Ca2+ content (26). Likewise, the inhibitory effect of increased [Mg2+]o on Ca2+ accumulation might be due to inhibition of mitochondrial reverse-mode Na+/Ca2+ exchange. The additive effect of increased [Mg2+]o and clonazepam on Ca2+ accumulation may suggest distinct modes of action. We cannot explain why or how cyclopiazonic acid actually augmented reoxygenation-mediated Ca2+ accumulation instead of reducing it as we had expected. Possibly, cyclopiazonic acid might lead to increased Ca2+ accumulation by inhibiting not only Ca2+ uptake by the SR but also Ca2+ transport (extrusion) by sarcolemma. The latter situation could make excess Ca2+ available to mitochondria. Because increased [Mg2+]o markedly attenuated Ca2+ accumulation induced by cyclopiazonic acid (to values lower than in cells exposed to only hypoxia and reoxygenation), it appears that the effect of Mg2+ may be explained either by the effect on sarcolemmal Ca2+ transport and/or reduced Ca2+ accumulation by mitochondria.
Effect of Mg2+ in
combination with clonazepam on 
m during
reoxygenation.
The maintenance of 
m is essential for cell survival
and function in all aerobic cell types. Disruption of

m has been shown to provoke mPT, which is an early
event in apoptotic and necrotic cell death, and mPT itself can
actually cause further disruption of 
m in a
self-amplifying manner (20). Because reoxygenated cells in
the presence of increased [Mg2+]o,
clonazepam, and combination of the two agents compared with nontreated
reoxygenated cells had 17, 40, and 50% higher red-to-green fluorescence ratios of JC-1, respectively, we suggest a protective effect of these agents by diminishing the fall in 
m.
Increased [Mg2+]o (5 mM) during reoxygenation
did not alter [Mg2+]i significantly in the
present data. This is in agreement with data from Headrik et al.
(12), showing improvement of myocardial energy metabolism
and function in both normoxic and ischemic rat hearts in the
presence of increased [Mg2+]o (>8.0 mM)
without alterations in [Mg2+]i. The role of
an extracellular locus of action for increased [Mg2+]o and/or involvement of a signal
transduction cascade stimulated by [Mg2+]o
therefore needs further investigation.
Interrelation between
Ca2+ accumulation and

m.
Our data showing an inverse correlation between Ca2+
accumulation with 
m in cells exposed to hypoxia and
reoxygenation suggest that the reduction of Ca2+
accumulation and preservation of 
m by
Mg2+ and clonazepam could be interrelated and involved in
protecting cardiomyocytes against damage by hypoxia and reoxygenation.
Kroemer et al. (20) reviewed the mechanisms by which
mitochondria may regulate life and death. The three major pathways were
briefly as follows: 1) signal transduction pathways via,
e.g., caspase activation and calcium; 2) redox catastrophy
because of glutathione depletion and augmented reactive oxygen species
production; and 3) bioenergetic catastrophy, which includes
ATP depletion and 
m disruption. The mechanism of
action of increased [Mg2+]o and clonazepam
alone and in combination on mitochondria cannot be determined based on
the present results and needs further investigation.
Effect of Mg2+ and
clonazepam on FSC and SSC.
Ischemia (hypoxia) and reperfusion (reoxygenation) can result
in apoptotic and necrotic cell death in myocardium (7,
15). The proportion of dead cells (trypan blue-positive cells)
and LDH release were increased significantly within 10 min of
reoxygenation in the present model (33). We
(34) have previously shown that increased
[Mg2+]o at the onset of reoxygenation reduced
LDH release, and the present study showed that clonazepam does the
same. Therefore, increased [Mg2+]o and
clonazepam attenuate disruption of the cell membrane associated with
cell necrosis and possibly late apoptosis. FSC and SSC reflect cell size and internal granularity and surface roughness, respectively (31). The decrease in FSC (cell shrinkage) paralleled
either by no change or an increase in SSC (membrane blebbing)
represents early changes during apoptosis (4).
Reoxygenated cells in our model showing reduced FSC and increased SSC
had therefore important characteristics of apoptotic cell death.
These changes may be related to hypercontracture of cardiomyocytes as
an early manifestation of irreversible cell injury (38).
This could be due to activation of actin-myosin cycling by restoring of
oxygen supply, ATP synthesis at still highly elevated
[Ca2+]i, and mitochondrial Ca2+
uptake (35). The samples taken at the onset of
reoxygenation and analyzed during the following 2-3 min showed a
small reduction in FSC and increase in SSC compared with normoxic
control cells; however, we assume that this is an immediate response to
reoxygenation and not to the hypoxia. Our previous study
(33) supports this view by showing that if cells were
fixed with paraformaldehyde (1%) at the onset of reoxygenation, they
had the same FSC and SSC as normoxic control cells. Therefore, it
appears that reoxygenation in this model induces apoptosis in
agreement with other reports (7, 15). Apoptosis
has been shown to be a dominant cause of cell death in rats and humans
(2, 28) after myocardial infarction. To our knowledge,
there is no data in the literature on the effect of increased
[Mg2+]o on apoptotic cell death during
reoxygenation or reperfusion of the myocardium. Clonazepam and the
combination of clonazepam and Mg2+ attenuated the
reoxygenation-induced reduction in FSC and increase in SSC. The
combination of clonazepam and Mg2+ tended to give larger
effects on both FSC and SSC. Kang et al. (15) showed that
apoptosis during reoxygenation was through a
mitochondrion-dependent pathway. As described in Interrelation between Ca2+ accumulation and 
m, the
decrease in 
m that has been associated with
apoptosis (20) was attenuated by clonazepam and
increased [Mg2+]o in the present model. These
results on FSC/SSC and 
m support each other and
indicate an antiapoptotic effect of clonazepam and increased
[Mg2+]o in this model. Internucleosomal
fragmentation of genomic DNA that still can be defined as a hallmark of
apoptosis (29) and activation of caspases during
reoxygenation in the presence of increased
[Mg2+]o need to be addressed in further studies.

m and reduced Ca2+ accumulation similar to that of clonazepam, we suggest
that a major protective mechanism for elevated
[Mg2+]o is to protect mitochondria against
Ca2+ overload and 
m loss. The
effectiveness of Mg2+ added at the onset of reoxygenation
appears to strengthen its potential in postischemic treatment.
| |
ACKNOWLEDGEMENTS |
|---|
M. N. Sharikabad is a research fellow of the Norwegian Council on Cardiovascular Diseases. This study was supported by the Norwegian Council on Cardiovascular Diseases and Research Forum, Ullevaal University Hospital.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. N. Sharikabad, Div. of Clinical Pharmacology and Toxicology, Dept. of Clinical Chemistry, Ullevaal Univ. Hosp., N-0407 Oslo, Norway (E-mail: m.n.sharikabad{at}ioks.uio.no).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 24 March 2001; accepted in final form 30 July 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Agus, ZS,
Kelepouris E,
Dukes I,
and
Morad M.
Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells.
Am J Physiol Cell Physiol
256:
C452-C455,
1989
2.
Anversa, P,
Cheng W,
Liu Y,
Leri A,
Redaelli G,
and
Kajstura J.
Apoptosis and myocardial infarction.
Basic Res Cardiol
93:
8-12,
1998.
3.
Barry, WH,
and
Smith TW.
Mechanisms of transmembrane calcium movement in cultured chick embryo ventricular cells.
J Physiol (Lond)
325:
243-260,
1982
4.
Bertho, AL,
Santiago MA,
and
Coutinho SG.
Flow cytometry in the study of cell death.
Mem Inst Oswaldo Cruz
95:
429-433,
2000[ISI][Medline].
5.
Borchgrevink, PC,
Bergan AS,
Bakoy OE,
and
Jynge P.
Magnesium and reperfusion of ischemic rat heart as assessed by 31P NMR.
Am J Physiol Heart Circ Physiol
256:
H195-H204,
1989
6.
Dennis, SC,
Coetzee WA,
Cragoe EJ, Jr,
and
Opie LH.
Effects of proton buffering and of amiloride derivatives on reperfusion arrhythmias in isolated rat hearts. Possible evidence for an arrhythmogenic role of Na+-H+ exchange.
Circ Res
66:
1156-1159,
1990
7.
Gottlieb, RA,
Burleson KO,
Kloner RA,
Babior BM,
and
Engler RL.
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
J Clin Invest
94:
1621-1628,
1994.
8.
Grinwald, PM,
and
Brosnahan C.
Sodium imbalance as a cause of calcium overload in post-hypoxic reoxygenation injury.
J Mol Cell Cardiol
19:
487-495,
1987[ISI][Medline].
9.
Gyamlani, G,
Parikh C,
and
Kulkarni AG.
Benefits of magnesium in acute myocardial infarction: timing is crucial.
Am Heart J
139:
703-706,
2000[Medline].
10.
Harkins, AB,
Kurebayashi N,
and
Baylor SM.
Resting myoplasmic free calcium in frog skeletal muscle fibers estimated with fluo-3 [see comments].
Biophys J
65:
865-881,
1993
11.
Hartzell, HC,
and
White RE.
Effects of magnesium on inactivation of the voltage-gated calcium current in cardiac myocytes.
J Gen Physiol
94:
745-767,
1989
12.
Headrick, JP,
McKirdy JC,
and
Willis RJ.
Functional and metabolic effects of extracellular magnesium in normoxic and ischemic myocardium.
Am J Physiol Heart Circ Physiol
275:
H917-H929,
1998
13.
Hurley, TW,
Ryan MP,
and
Brinck RW.
Changes of cytosolic Ca2+ interfere with measurements of cytosolic Mg2+ using mag-fura 2.
Am J Physiol Cell Physiol
263:
C300-C307,
1992
14.
Ichiba, T,
Matsuda N,
Takemoto N,
Ishiguro S,
Kuroda H,
and
Mori T.
Regulation of intracellular calcium concentrations by calcium and magnesium in cardioplegic solutions protects rat neonatal myocytes from simulated ischemia.
J Mol Cell Cardiol
30:
1105-1114,
1998[ISI][Medline].
15.
Kang, PM,
Haunstetter A,
Aoki H,
Usheva A,
and
Izumo S.
Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation.
Circ Res
87:
118-125,
2000
16.
Kihara, Y,
Grossman W,
and
Morgan JP.
Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart.
Circ Res
65:
1029-1044,
1989
17.
Kimura, J.
Effects of external Mg2+ on the Na-Ca exchange current in guinea pig cardiac myocytes.
Ann NY Acad Sci
779:
515-520,
1996[ISI][Medline].
18.
Koss, KL,
Putnam RW,
and
Grubbs RD.
Mg2+ buffering in cultured chick ventricular myocytes: quantitation and modulation by Ca2+.
Am J Physiol Cell Physiol
264:
C1259-C1269,
1993
19.
Kowaltowski, AJ,
Naia-da-Silva ES,
Castilho RF,
and
Vercesi AE.
Ca2+-stimulated mitochondrial reactive oxygen species generation and permeability transition are inhibited by dibucaine or Mg2+.
Arch Biochem Biophys
359:
77-81,
1998[ISI][Medline].
20.
Kroemer, G,
Dallaporta B,
and
Resche-Rigon M.
The mitochondrial death/life regulator in apoptosis and necrosis.
Annu Rev Physiol
60:
619-642,
1998[ISI][Medline].
21.
Ladilov, Y,
Haffner S,
Balser-Schafer C,
Maxeiner H,
and
Piper HM.
Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger.
Am J Physiol Heart Circ Physiol
276:
H1868-H1876,
1999
22.
Leyssens, A,
Nowicky AV,
Patterson L,
Crompton M,
and
Duchen MR.
The relationship between mitochondrial state, ATP hydrolysis, [Mg2+]i and [Ca2+]i studied in isolated rat cardiomyocytes.
J Physiol (Lond)
496:
111-128,
1996[ISI][Medline].
23.
Lochner, A,
van der Merwe N,
de Villiers M,
Steinmann C,
and
Kotze JC.
Mitochondrial Ca2+ fluxes and levels during ischaemia and reperfusion: possible mechanisms.
Biochim Biophys Acta
927:
8-17,
1987[Medline].
24.
Mathur, A,
Hong Y,
Kemp BK,
Barrientos AA,
and
Erusalimsky JD.
Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes [see comments].
Cardiovasc Res
46:
126-138,
2000
25.
Murphy, JG,
Smith TW,
and
Marsh JD.
Mechanisms of reoxygenation-induced calcium overload in cultured chick embryo heart cells.
Am J Physiol Heart Circ Physiol
254:
H1133-H1141,
1988
26.
Nayler, WG.
The role of calcium in the ischemic myocardium.
Am J Pathol
102:
262-270,
1981[Abstract].
27.
Nishida, M,
Borzak S,
Kraemer B,
Navas JP,
Kelly RA,
Smith TW,
and
Marsh JD.
Role of cation gradients in hypercontracture of myocytes during simulated ischemia and reperfusion.
Am J Physiol Heart Circ Physiol
264:
H1896-H1906,
1993
28.
Palojoki, E,
Saraste A,
Eriksson A,
Pulkki K,
Kallajoki M,
Voipio-Pulkki LM,
and
Tikkanen I.
Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.
Am J Physiol Heart Circ Physiol
280:
H2726-H2731,
2001
29.
Saraste, A,
and
Pulkki K.
Morphologic and biochemical hallmarks of apoptosis.
Cardiovasc Res
45:
528-537,
2000
30.
Schafer, C,
Ladilov YV,
Siegmund B,
and
Piper HM.
Importance of bicarbonate transport for protection of cardiomyocytes against reoxygenation injur